A novel HLA allele, HLA-B*07:248, detected in a Chinese hematopoietic stem cell donor and platelet donor

HLA. 2023 Jan;101(1):49-51. doi: 10.1111/tan.14794. Epub 2022 Sep 19.

Authors

Xiao-Feng Li^{1

2

3

4}, Min-Xi Li⁵, Xu Zhang^{1

2

3}, Feng-Qiu Lin^{1

2

3}, Jian-Ping Li^{1

2

3

4

6

7}

Affiliations

¹ Transfusion Medicine Institute, Liaoning Blood Center, Shenyang, China.
² Liaoning Provincial Key Laboratory for Blood Safety Research, Shenyang, China.
³ Key Laboratory for Blood Safety Research of Shenyang, Shenyang, China.
⁴ Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, China.
⁵ Department of Hematology, The Forth Affiliated Hospital of China Medical University, Shenyang, China.
⁶ Transfusion Medicine Institute, Harbin Blood Center, Harbin, China.
⁷ Scientific Research Center of Shenyang Municipal Health Commission, Shenyang, China.

PMID: 36045609
DOI: 10.1111/tan.14794

Abstract

HLA-B*07:248 has one nucleotide change from HLA-B*07:18:01 where Tyrosine (Y) is changed to Serine (S).

Keywords: HLA-B*07:248; a novel allele; sequence-based typing.

© 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Alleles
East Asian People*
Hematopoietic Stem Cells*
Humans

Substances

HLA-B*07 antigen